Seattle Vaccine Research Fund

Analysis

Seattle Vaccine Research Fund is a registered charity in United States, based in Seattle, WA. It received its IRS tax-exemption ruling in June 2005, 21 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a supporting organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Seattle Vaccine Research Fund reported income of $89k and spending of $2,999, leaving 97% of income unspent that year. Across the 3 years on record, from June 2020 to June 2023, income fell from $2.7m to $89k (-97%), an average of -82% a year. The sharpest change came in the year to June 2023, when income rose by 1519%. Over the whole period it spent 22% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Seattle Vaccine Research Fund sits at the 25th percentile: it is larger than about 25% of them. Against every charity in United States with reported income it ranks in the 34th percentile, and in the 29th percentile within WA. Charities of a similar size with the same main cause include Multiple Sclerosis Alliance of Virginia ($89k), Trisomy 18 Support Inc ($89k) and New Beginnings Intervention Center ($89k).

At year end it held assets of $2.6m against liabilities of $0, net assets of $2.6m.